|
Volumn 18, Issue 8, 2012, Pages 598-606
|
Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
GLUCOCORTICOID;
AGED;
ARTICLE;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
COGNITIVE DEFECT;
DRUG COMBINATION;
DYSPNEA;
EQUIPMENT DESIGN;
FEMALE;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
NEBULIZER;
NURSING HOME;
PATHOPHYSIOLOGY;
PRACTICE GUIDELINE;
PREVALENCE;
PSYCHOLOGICAL RATING SCALE;
RETROSPECTIVE STUDY;
STATISTICS;
UNITED STATES;
ADMINISTRATION, INHALATION;
ADRENERGIC BETA-AGONISTS;
AGED;
AGED, 80 AND OVER;
CHOLINERGIC ANTAGONISTS;
COGNITION DISORDERS;
DRUG THERAPY, COMBINATION;
DYSPNEA;
EQUIPMENT DESIGN;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
MALE;
MIDDLE AGED;
NEBULIZERS AND VAPORIZERS;
NURSING HOMES;
PRACTICE GUIDELINES AS TOPIC;
PREVALENCE;
PSYCHIATRIC STATUS RATING SCALES;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
RETROSPECTIVE STUDIES;
UNITED STATES;
|
EID: 84874571553
PISSN: None
EISSN: 1944706X
Source Type: Journal
DOI: 10.18553/jmcp.2012.18.8.598 Document Type: Article |
Times cited : (36)
|
References (0)
|